Acutus Medical Inc. (AFIB): Price and Financial Metrics Recent IPO

Acutus Medical Inc. (AFIB) Recent IPO

Today's Latest Price: $27.00 USD

1.42 (-5.00%)

Updated Dec 1 6:55pm

Add AFIB to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 143 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

AFIB Stock Price Chart Interactive Chart >

Price chart for AFIB

AFIB Price/Volume Stats

Current price $27.00 52-week high $38.99
Prev. close $28.42 52-week low $22.26
Day low $25.81 Volume 187,700
Day high $28.90 Avg. volume 197,607
50-day MA $26.49 Dividend yield N/A
200-day MA $0.00 Market Cap 751.84M

Acutus Medical Inc. (AFIB) Company Bio

Acutus Medical develops medical technologies to treat complex cardiac arrhythmia. The company's platform displays the heart’s true activation pattern, turning the chaos of a complex arrhythmia into a clear vision for electrophysiologists. Acutus Medical is a privately funded company founded in 2011 and based in Carlsbad, California. Its products are co-developed in the U.S. and Europe with an exceptional team of medical scientists, biomedical engineers, and other professionals.

AFIB Latest News Stream

Event/Time News Detail
Loading, please wait...

AFIB Latest Social Stream

Loading social stream, please wait...

View Full AFIB Social Stream

Latest AFIB News From Around the Web

Below are the latest news stories about Acutus Medical Inc that investors may wish to consider to help them evaluate AFIB as an investment opportunity.

Acutus Medical, Inc. (AFIB) CEO Vince Burgess on Q2 2020 Results - Earnings Call Transcript

Acutus Medical, Inc. (AFIB) Q2 2020 Results Earnings Conference Call September 17, 2020, 04:30 PM ET Company Participants Caroline Corner - Investor Relations Vince Burgess - President and Chief Executive Officer Gary Doherty - Chief Financial Officer Conference Call Participants Robbie Marcus - JPMorgan Bob Hopkins - Bank of America...

SA Transcripts on Seeking Alpha | September 18, 2020

FDA OKs Acutus Medical's next-gen catheter

FDA grants 510(k) clearance to Acutus Medical's (AFIB) second-generation AcQMed 3D imaging and mapping catheter.The company says the device is the world’s only integrated high-resolution ultrasound-based imaging and non-contact mapping catheter capable of capturing cardiac imaging information in addition to cardiac activation mapping.Shares up 4% after hours....

Seeking Alpha | September 17, 2020

Read More 'AFIB' Stories Here

AFIB Price Returns

1-mo 17.39%
3-mo -21.24%
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.6491 seconds.